Literature DB >> 15110801

Development of effective immunotherapy for the treatment of patients with cancer.

Steven A Rosenberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15110801      PMCID： PMC1471995          DOI： 10.1016/j.jamcollsurg.2004.01.025

Source DB:  PubMed          Journal:  J Am Coll Surg        ISSN： 1072-7515            Impact factor:   6.113


× No keyword cloud information.
  38 in total

1.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

2.  Generation of tumor-infiltrating lymphocyte cultures for use in adoptive transfer therapy for melanoma patients.

Authors:  Mark E Dudley; John R Wunderlich; Thomas E Shelton; Jos Even; Steven A Rosenberg
Journal:  J Immunother       Date:  2003 Jul-Aug       Impact factor: 4.456

3.  Recombinant fowlpox viruses encoding the anchor-modified gp100 melanoma antigen can generate antitumor immune responses in patients with metastatic melanoma.

Authors:  Steven A Rosenberg; James C Yang; Douglas J Schwartzentruber; Patrick Hwu; Suzanne L Topalian; Richard M Sherry; Nicholas P Restifo; John R Wunderlich; Claudia A Seipp; Linda Rogers-Freezer; Kathleen E Morton; Sharon A Mavroukakis; Linda Gritz; Dennis L Panicali; Donald E White
Journal:  Clin Cancer Res       Date:  2003-08-01       Impact factor: 12.531

4.  Observations on the systemic administration of autologous lymphokine-activated killer cells and recombinant interleukin-2 to patients with metastatic cancer.

Authors:  S A Rosenberg; M T Lotze; L M Muul; S Leitman; A E Chang; S E Ettinghausen; Y L Matory; J M Skibber; E Shiloni; J T Vetto
Journal:  N Engl J Med       Date:  1985-12-05       Impact factor: 91.245

5.  Biological activity of recombinant human interleukin-2 produced in Escherichia coli.

Authors:  S A Rosenberg; E A Grimm; M McGrogan; M Doyle; E Kawasaki; K Koths; D F Mark
Journal:  Science       Date:  1984-03-30       Impact factor: 47.728

6.  A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes.

Authors:  S A Rosenberg; P Spiess; R Lafreniere
Journal:  Science       Date:  1986-09-19       Impact factor: 47.728

7.  Structure and expression of a cloned cDNA for human interleukin-2.

Authors:  T Taniguchi; H Matsui; T Fujita; C Takaoka; N Kashima; R Yoshimoto; J Hamuro
Journal:  Nature       Date:  1983 Mar 24-30       Impact factor: 49.962

8.  Inability to immunize patients with metastatic melanoma using plasmid DNA encoding the gp100 melanoma-melanocyte antigen.

Authors:  Steven A Rosenberg; James C Yang; Richard M Sherry; Patrick Hwu; Suzanne L Topalian; Douglas J Schwartzentruber; Nicholas P Restifo; Leah R Haworth; Claudia A Seipp; Linda J Freezer; Kathleen E Morton; Sharon A Mavroukakis; Donald E White
Journal:  Hum Gene Ther       Date:  2003-05-20       Impact factor: 5.695

9.  Defective CD8 T cell memory following acute infection without CD4 T cell help.

Authors:  Joseph C Sun; Michael J Bevan
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

10.  Regression of established pulmonary metastases and subcutaneous tumor mediated by the systemic administration of high-dose recombinant interleukin 2.

Authors:  S A Rosenberg; J J Mulé; P J Spiess; C M Reichert; S L Schwarz
Journal:  J Exp Med       Date:  1985-05-01       Impact factor: 14.307
View more
  14 in total

1.  High-avidity autoreactive CD4+ T cells induce host CTL, overcome T(regs) and mediate tumor destruction.

Authors:  Andrew G Brandmaier; Wolfgang W Leitner; Sung P Ha; John Sidney; Nicholas P Restifo; Christopher E Touloukian
Journal:  J Immunother       Date:  2009-09       Impact factor: 4.456

Review 2.  Toward effective immunotherapy for the treatment of malignant brain tumors.

Authors:  Duane A Mitchell; John H Sampson
Journal:  Neurotherapeutics       Date:  2009-07       Impact factor: 7.620

3.  Development of Novel ImmunoPET Tracers to Image Human PD-1 Checkpoint Expression on Tumor-Infiltrating Lymphocytes in a Humanized Mouse Model.

Authors:  Arutselvan Natarajan; Aaron T Mayer; Robert E Reeves; Claude M Nagamine; Sanjiv Sam Gambhir
Journal:  Mol Imaging Biol       Date:  2017-12       Impact factor: 3.488

4.  Respiratory Homeostasis and Exploitation of the Immune System for Lung Cancer Vaccines.

Authors:  Adam Yagui-Beltrán; Lisa M Coussens; David M Jablons
Journal:  US Oncol       Date:  2009

Review 5.  Targeting the PD-1 pathway: a promising future for the treatment of melanoma.

Authors:  Andrew Mamalis; Manveer Garcha; Jared Jagdeo
Journal:  Arch Dermatol Res       Date:  2014-03-11       Impact factor: 3.017

Review 6.  CD25+ CD4+ regulatory T-cells in cancer.

Authors:  David C Linehan; Peter S Goedegebuure
Journal:  Immunol Res       Date:  2005       Impact factor: 2.829

7.  Peripheral blood CD40-CD40L expression in human breast cancer.

Authors:  W Pan; J Gong; C Yang; R Feng; F Guo; Y Sun; H Chen
Journal:  Ir J Med Sci       Date:  2013-02-28       Impact factor: 1.568

8.  Cell density plays a critical role in ex vivo expansion of T cells for adoptive immunotherapy.

Authors:  Qiangzhong Ma; Yawen Wang; Agnes Shuk-Yee Lo; Erica M Gomes; Richard P Junghans
Journal:  J Biomed Biotechnol       Date:  2010-06-30

9.  Selective inhibition of regulatory T cells by targeting the PI3K-Akt pathway.

Authors:  Rasha Abu-Eid; Raed N Samara; Laurent Ozbun; Maher Y Abdalla; Jay A Berzofsky; Kevin M Friedman; Mikayel Mkrtichyan; Samir N Khleif
Journal:  Cancer Immunol Res       Date:  2014-07-30       Impact factor: 11.151

Review 10.  Immunological and clinical significance of HLA class I antigen processing machinery component defects in malignant cells.

Authors:  Fernando Concha-Benavente; Raghvendra Srivastava; Soldano Ferrone; Robert L Ferris
Journal:  Oral Oncol       Date:  2016-06-02       Impact factor: 5.337
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.